Edwards Lifesciences stock heads into the open after market drop
Published on 09/24/2026 at 02:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edwards Lifesciences stock had a documented opening price of USD 88.81 on the NYSE on September 23, 2026. The broader U.S. market fell that session, with the S&P 500 down 0.8 percent to 7,706.03.
September 23, 2026 in numbers
Edwards Lifesciences Corporation (ISIN US28176E1082, NYSE: EW) opened at USD 88.81 on September 23, 2026, according to MarketBeat. The same source reported a market capitalization of USD 51.14 billion and a 52-week range from USD 72.30 to USD 96.29.
As ABC News reported, the S&P 500 fell 58.61 points to 7,706.03, while the Nasdaq Composite dropped 308.24 points, or 1.1 percent, to 26,936.04. The session backdrop included a rise in the 10-year Treasury yield to 5.11 percent after stronger economic data increased inflation concerns.
September 24, 2026 outlook
Market conditions remain the directly substantiated consideration for the stock ahead of the U.S. open. The medical technology sector may be affected by broader equity pressure and higher bond yields, but the available dated evidence does not establish a separate Edwards Lifesciences catalyst for September 24, 2026.
